CHNA

Loncar China BioPharma ETF

Down$22.97
$-0.03
(-0.13%)
As of 12:00:00 AM EDT | 10/18/19  |  Market Closed

CHNA Trading Data

Open

$23.09

Low Price

$22.97

High Price

$23.09

Previous Last Price

$23

Bid Size

$0 X 0

Ask Size

$0 X 0

CHNA Portfolio Data

AUM

$6,897,000

Shares

300

PE Ratio

16.55

Price / Book Ratio

2.74

Expense Ratio

0.79

Net Asset Value

$22.99

Volume

Volume

2,100

Avg. Volume (YDT)

3,415

Dollar Volume

$0

Weekly Avg. Volume

1,720

Monthly Avg. Volume

2,990

Quarterly Avg. Volume

5,492

CHNA Fund Description

The China BioPharma ETF offers exposure to a basket of companies powering China's biopharmaceutical industry. With a long-term goal of steering its economy towards innovation, China aims be a global leader in medicine. CHNA seeks to invest in this opportunity with the convenience of one security that trades in the United States. It invests in pharmaceutical companies, biotech companies,drug manufacturers, diagnostics companies, wholesalers, distributors, and service providers that have a strategic focus in growing China's drug industry.

CHNA Chart

CHNA Summary

Fund Family

Exchange Traded Concepts

Tracks This Index

Loncar China BioPharma ETF

Inception Date

2018-08-14

Asset Class

Equity

Asset Class Size

CHNA Classification

Region (General)

Asia-Pacific

Region (Specific)

China

Sector

Health Care

Equity Index

Leveraged Family

CHNA Holdings

Top 10 Holdings

CSPC PHARMACEUTICA (1093 HK)
5.89%
WUXI APPTEC CO LTD (2359 HK)
5.41%
SINO BIOPHARMACEUT (1177 HK)
5.09%
HANSOH PHARMACEUTI (3692 HK)
5.04%
CHINA MEDICAL SYS (867 HK)
4.4%
WUXI BIOLOGICS (CA (2269 HK)
4.35%
SINOPHARM GROUP CO (1099 HK)
3.94%
CANSINO BIOLOGICS (6185 HK)
3.58%
CHINA BIOLOGIC PRODS HLDGS INC COM (CBPO)
3.52%
LIVZON PHARMACEUTI (1513 HK)
3.49%

Total CHNA Holdings

Total Holdings: 31

CSPC PHARMACEUTICA (1093 HK)
5.89%
WUXI APPTEC CO LTD (2359 HK)
5.41%
SINO BIOPHARMACEUT (1177 HK)
5.09%
HANSOH PHARMACEUTI (3692 HK)
5.04%
CHINA MEDICAL SYS (867 HK)
4.4%
WUXI BIOLOGICS (CA (2269 HK)
4.35%
SINOPHARM GROUP CO (1099 HK)
3.94%
CANSINO BIOLOGICS (6185 HK)
3.58%
CHINA BIOLOGIC PRODS HLDGS INC COM (CBPO)
3.52%
LIVZON PHARMACEUTI (1513 HK)
3.49%
3SBIO INC (1530 HK)
3.4%
YICHANG HEC CHANGJ (1558 HK)
3.33%
LUYE PHARMA GP LTD (2186 HK)
3.29%
ZAI LAB LTD (ZLAB)
3.19%
SHANGHAI PHARMACEU (2607 HK)
3.18%
INNOVENT BIOLOGICS (1801 HK)
3.15%
SHANGHAI FOSUN PHA (2196 HK)
3.1%
BEIGENE LTD (BGNE)
3.03%
SSY GROUP LIMITED (2005 HK)
2.93%
VIVA BIOTECH HOLDI (1873 HK)
2.93%
HUTCHISON CHINA MEDITECH LTD SPONSORED ADR (HCM)
2.87%
SHANGHAI JUNSHI BI (1877 HK)
2.87%
CHINA RES PHARM GR (3320 HK)
2.81%
GUANGZHOU BAIYUNSH (874 HK)
2.76%
GENSCRIPT BIOTECH (1548 HK)
2.75%
CELLULAR BIOMEDICINE GROUP INC COM NEW (CBMG)
2.63%
SHANGHAI HAOHAI BI (6826 HK)
2.61%
CASI PHARMACEUTICALS INC (CASI)
2.29%
SIHUAN PHARM HLDG (460 HK)
2.11%
Cash & Other (Cash&Other)
0.07%
Loncar CHINA BIOPHARMA ETF (CHNA)
0%

CHNA Technicals

Alpha

0

Beta

-1.38

Leverage

Long

Standard Deviation

1.41

CHNA Dividends

Dividend Date

Latest Dividend

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

CHNA Performance

YTD Return

19.77%

1 Year Return

16.02%

3 Year Return

0%

5 Year Return

0%

10 Year Return

-8.51%

CHNA Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.